New Delhi | February 24, 2026: Indraprastha Apollo Hospitals has introduced the Varian Edge® Radiosurgery System with Hyperarc Technology, strengthening its advanced cancer care capabilities and expanding treatment options for complex and hard-to-reach tumours.
This launch marks a major milestone in radiation oncology, combining sub-millimetre precision, advanced imaging, and motion management to deliver highly targeted radiation therapy while minimizing exposure to surrounding healthy tissue.
Clinical Advantages
- Real-time tumour tracking: Radiation beam continuously adjusts to tumour movement during breathing, ensuring consistent accuracy.
- Deep Inspiration Breath Hold (DIBH): Particularly beneficial for left-sided breast cancers, reducing radiation exposure to the heart.
- Enhanced imaging clarity: Improves precision in abdominal, liver, lung, gastrointestinal, and genitourinary tumours, where organ motion and gas interference often impact accuracy.
- Multiple metastases treatment: Ability to treat several lesions in a single session, reducing treatment time to less than one-third of conventional LINAC or SRS therapies.
- Synchronised beam and couch movement: Enables continuous, precise radiation delivery, fewer radiation “hits,” and improved patient comfort.
Dr. G K Jadhav, Senior Consultant, Radiation Oncology, said: “The Varian Edge platform gives us a sharper, more versatile tool to manage a wide spectrum of tumours, from tiny lesions to large, complex cases, even in challenging locations. It meaningfully expands our treatment options and enhances clinical outcomes.”
Dr. Sapna Manocha Verma, Senior Consultant, Radiation Oncology, added: “What sets apart this technology is its ability to track tumours in real time while protecting surrounding tissue. For patients, this translates into shorter treatment times, fewer side effects, and faster recovery.”
Dr. Robin Khosa, Senior Consultant, Radiation Oncology, noted: “The Varian Edge® Radiosurgery System with Hyperarc Technology represents a major advancement in precision radiation therapy. Its sub-millimetre accuracy allows us to treat complex cases, including multiple brain metastases, with greater safety and confidence.”
Impact on Cancer Care
The system is particularly impactful for tumours in delicate or hard-to-reach areas, where precision and motion management are critical. Enhanced imaging quality and sharper resolution enable clinicians to:
- Reduce treatment margins.
- Safely deliver higher radiation doses when required.
- Improve cure rates while lowering normal tissue toxicity.
With this launch, Indraprastha Apollo Hospitals reinforces its commitment to combining cutting-edge technology with deep clinical expertise, ensuring better outcomes, fewer side effects, and improved patient quality of life.
About Indraprastha Apollo Hospitals
- India’s first JCI-accredited hospital, commissioned in July 1996.
- Joint venture between the Government of Delhi and Apollo Hospitals Enterprise Limited.
- Spread over 15 acres, housing 57 specialties, 700+ operational beds, 19 operation theatres, and 138 ICU beds.
- Leading programmes in kidney and liver transplants, with India’s first successful paediatric and adult liver transplants performed here.
- Introduced advanced technologies including 64-slice CT, 3 Tesla MRI, Novalis Tx, integrated PET Suite, ZAP-X Gyroscopic Radiosurgery Platform, and RADIXACT-X9.
- Consistently ranked among the top 10 hospitals in India by The Week survey.
🌐 Website: www.apollohospdelhi.com
